Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Monday 27 October 2014 12:15 pm  |  Updated:  Friday 07 June 2019 2:26 pm

How to test for Ebola: Jellyfish DNA on blotting paper could be used to identify virus within 30 minutes

By: Sarah Spickernell

Add as a preferred source on Google

It could be about to become much cheaper and easier to test for Ebola, thanks to a new identification method involving DNA-programmed blotting paper.
 
A group of scientists in the US were able to detect the virus after discs of paper were embedded with DNA and RNA fragments from jellyfish and other organisms.
 
The material was freeze-dried and preserved at room temperature, but when water was added it became reactivated. Once active, the paper changed colour if a particular target – such as a segment of Ebola viral RNA – was present in the water.
 
This is because the target fragment attached itself to a gene switch in the DNA, instigating the production of a colourful substance such as the protein that gives jellyfish their green glow under ultraviolet light or the bacterial proteins that produce visible colour changes. The colour the paper changed to revealed which of the target pathogens was present.
 
"We were surprised at how well these materials worked after being freeze dried," lead researcher Jim Collins told the BBC. "Once they're rehydrated, these biological circuits function in these small paper disks as if they were inside a living cell."
 
The results, published in the journal Cell, show how they were able to detect two strains of the virus in just 30 minutes, including the Zaire strain currently taking the lives of thousands of people in west Africa. 
 
This was much faster than the speed of Ebola identification methods currently available. Not only that, but the whole test was conducted using an estimated $21 worth of materials – other tests are much more expensive than this. 
 
The cost could be reduced even further if DNA circuits are made “in-house” instead, Collins explained to the New Scientist. “It's the order of pennies," he said. "The advantages we're bringing include low cost, no refrigeration needed and fast output.”
 
Over 10,000 people have been infected wit Ebola and almost 5,000 have died since the start of the outbreak in December last year, according to the latest figures from the World Health Organisation (WHO). 
 
Earlier this month, the assistant director-general of the WHO warned that there could be as many as 10,000 new cases per week by December.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Brewdog chief executive quits after only one year

  • Burnham tax plans spark investor rush to bank capital gains

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Canary Wharf’s reinvention is a triumph

More from City PM

  • QEPOS Solution Ltd and DNA Payments Partner to Bring Streamlined ePOS Payments to UK Hospitality and Retail Businesses

    Business Wire
  • AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas

    Business Wire
  • Promega Receives SBTi Validation for Near-Term Science-Based Emissions Reduction Targets

    Business Wire
  • Olympia developer: Britain’s planning system doesn’t reward delivery

    Opinion
    John Hitchox, founder of YOO Group, in a professional setting discussing innovative design and architecture strategies.
  • MotoGP and manufacturers sign first Formula 1-style Concorde agreement

    Sport Business
    Getty Images logo displayed on a digital screen, representing the brands presence in the media and photography industry
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Exclusive: O2 Arena bosses open to hosting another Formula 1 launch event

    Sport Business
    Breaking news event coverage with journalists and cameras capturing a live press conference in a bustling city environment
  • Government is set to deal major blow to Big Tech’s moves into sports rights

    Sport Business
    Without the article title or content provided, Im unable to generate a specific alt text for the image. Please provide mor...

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy